Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy.
Chen J, Amoozgar Z, Liu X, Aoki S, Liu Z, Shin S, Matsui A, Pu Z, Lei PJ, Datta M, Zhu L, Ruan Z, Shi L, Staiculescu D, Inoue K, Munn LL, Fukumura D, Huang P, Bardeesy N, Ho WJ, Jain RK, Duda DG.
Chen J, et al. Among authors: liu z, liu x.
bioRxiv [Preprint]. 2023 Jan 27:2023.01.26.525680. doi: 10.1101/2023.01.26.525680.
bioRxiv. 2023.
PMID: 36747853
Free PMC article.
Updated.
Preprint.